SEARCH

SEARCH BY CITATION

References

  • International Batten Disease Consortium. (1995) Isolation of a novel gene underlying Batten disease, CLN3. The International Batten Disease Consortium. Cell 82, 949957.
  • Akaike T., Suga M. and Maeda H. (1998) Free radicals in viral pathogenesis: molecular mechanisms involving superoxide and NO. Proc. Soc. Exp. Biol. Med. 217, 6473.
  • Allan S. M., Tyrrell P. J. and Rothwell N. J. (2005) Interleukin-1 and neuronal injury. Nat. Rev. Immunol. 5, 629640.
  • Ankarcrona M., Dypbukt J. M., Bonfoco E., Zhivotovsky B., Orrenius S., Lipton S. A. and Nicotera P. (1995) Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 15, 961973.
  • Arai H., Furuya T., Yasuda T., Miura M., Mizuno Y. and Mochizuki H. (2004) Neurotoxic effects of lipopolysaccharide on nigral dopaminergic neurons are mediated by microglial activation, interleukin-1beta, and expression of caspase-11 in mice. J. Biol. Chem. 279, 5164751653.
  • Bal-Price A. and Brown G. C. (2001) Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity. J. Neurosci. 21, 64806491.
  • Beattie E. C., Stellwagen D., Morishita W., Bresnahan J. C., Ha B. K., Von Zastrow M., Beattie M. S. and Malenka R. C. (2002) Control of synaptic strength by glial TNFalpha. Science 295, 22822285.
  • Benedict J. W., Sommers C. A. and Pearce D. A. (2007) Progressive oxidative damage in the central nervous system of a murine model for juvenile Batten disease. J. Neurosci. Res. 85, 28822891.
  • Bennett M. V., Garre J. M., Orellana J. A., Bukauskas F. F., Nedergaard M. and Saez J. C. (2012) Connexin and pannexin hemichannels in inflammatory responses of glia and neurons. Brain Res. 1487, 315.
  • Bledi Y., Domb A. J. and Linial M. (2000) Culturing neuronal cells on surfaces coated by a novel polyethyleneimine-based polymer. Brain Res. Brain Res. Protoc. 5, 282289.
  • Block M. L., Zecca L. and Hong J. S. (2007) Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosci. 8, 5769.
  • Brugg B., Michel P. P., Agid Y. and Ruberg M. (1996) Ceramide induces apoptosis in cultured mesencephalic neurons. J. Neurochem. 66, 733739.
  • Byun K., Bayarsaikhan E., Kim D. et al. (2012) Induction of neuronal death by microglial AGE-albumin: implications for Alzheimer's disease. PLoS ONE 7, e37917.
  • Cao Y., Staropoli J. F., Biswas S., Espinola J. A., MacDonald M. E., Lee J. M. and Cotman S. L. (2011) Distinct early molecular responses to mutations causing vLINCL and JNCL presage ATP synthase subunit C accumulation in cerebellar cells. PLoS ONE 6, e17118.
  • Castaneda J. A., Lim M. J., Cooper J. D. and Pearce D. A. (2008) Immune system irregularities in lysosomal storage disorders. Acta Neuropathol. 115, 159174.
  • Chattopadhyay S., Ito M., Cooper J. D., Brooks A. I., Curran T. M., Powers J. M. and Pearce D. A. (2002) An autoantibody inhibitory to glutamic acid decarboxylase in the neurodegenerative disorder Batten disease. Hum. Mol. Genet. 11, 14211431.
  • Codolo G., Plotegher N., Pozzobon T., Brucale M., Tessari I., Bubacco L. and de Bernard M. (2013) Triggering of inflammasome by aggregated alpha-synuclein, an inflammatory response in synucleinopathies. PLoS ONE 8, e55375.
  • Cotman S. L., Vrbanac V., Lebel L. A. et al. (2002) Cln3(Deltaex7/8) knock-in mice with the common JNCL mutation exhibit progressive neurologic disease that begins before birth. Hum. Mol. Genet. 11, 27092721.
  • Cutler R. G., Haughey N. J., Tammara A., McArthur J. C., Nath A., Reid R., Vargas D. L., Pardo C. A. and Mattson M. P. (2004) Dysregulation of sphingolipid and sterol metabolism by ApoE4 in HIV dementia. Neurology 63, 626630.
  • Dix M. M., Simon G. M. and Cravatt B. F. (2008) Global mapping of the topography and magnitude of proteolytic events in apoptosis. Cell 134, 679691.
  • Esen N., Tanga F. Y., DeLeo J. A. and Kielian T. (2004) Toll-like receptor 2 (TLR2) mediates astrocyte activation in response to the Gram-positive bacterium Staphylococcus aureus. J. Neurochem. 88, 746758.
  • Eugenin E. A., Basilio D., Saez J. C., Orellana J. A., Raine C. S., Bukauskas F., Bennett M. V. and Berman J. W. (2012) The role of gap junction channels during physiologic and pathologic conditions of the human central nervous system. J. Neuroimmune Pharmacol. 7, 499518.
  • Fehniger T. A. and Caligiuri M. A. (2001) Interleukin 15: biology and relevance to human disease. Blood 97, 1432.
  • Fellner L., Jellinger K. A., Wenning G. K. and Stefanova N. (2011) Glial dysfunction in the pathogenesis of alpha-synucleinopathies: emerging concepts. Acta Neuropathol. 121, 675693.
  • Ferrari D., Chiozzi P., Falzoni S., Hanau S. and Di Virgilio F. (1997) Purinergic modulation of interleukin-1 beta release from microglial cells stimulated with bacterial endotoxin. J. Exp. Med. 185, 579582.
  • Filippov V., Song M. A., Zhang K., Vinters H. V., Tung S., Kirsch W. M., Yang J. and Duerksen-Hughes P. J. (2012) Increased ceramide in brains with Alzheimer's and other neurodegenerative diseases. J. Alzheimers Dis. 29, 537547.
  • Finn R., Kovacs A. D. and Pearce D. A. (2011) Altered sensitivity of cerebellar granule cells to glutamate receptor overactivation in the Cln3(Deltaex7/8)-knock-in mouse model of juvenile neuronal ceroid lipofuscinosis. Neurochem. Int. 58, 648655.
  • Franchi L., Eigenbrod T., Munoz-Planillo R. and Nunez G. (2009) The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat. Immunol. 10, 241247.
  • Getty A. L. and Pearce D. A. (2011) Interactions of the proteins of neuronal ceroid lipofuscinosis: clues to function. Cell. Mol. Life Sci. 68, 453474.
  • Glass C. K., Saijo K., Winner B., Marchetto M. C. and Gage F. H. (2010) Mechanisms underlying inflammation in neurodegeneration. Cell 140, 918934.
  • Halle A., Hornung V., Petzold G. C. et al. (2008) The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat. Immunol. 9, 857865.
  • Hanamsagar R., Torres V. and Kielian T. (2011) Inflammasome activation and IL-1beta/IL-18 processing are influenced by distinct pathways in microglia. J. Neurochem. 119, 736748.
  • Hanamsagar R., Hanke M. L. and Kielian T. (2012) Toll-like receptor (TLR) and inflammasome actions in the central nervous system. Trends Immunol. 33, 333342.
  • Hensley K. (2010) Neuroinflammation in Alzheimer's disease: mechanisms, pathologic consequences, and potential for therapeutic manipulation. J. Alzheimers Dis. 21, 114.
  • Herrmann P., Druckrey-Fiskaaen C., Kouznetsova E., Heinitz K., Bigl M., Cotman S. L. and Schliebs R. (2008) Developmental impairments of select neurotransmitter systems in brains of Cln3(Deltaex7/8) knock-in mice, an animal model of juvenile neuronal ceroid lipofuscinosis. J. Neurosci. Res. 86, 18571870.
  • Holm T. H., Draeby D. and Owens T. (2012) Microglia are required for astroglial Toll-like receptor 4 response and for optimal TLR2 and TLR3 response. Glia 60, 630638.
  • Hornung V. and Latz E. (2010) Critical functions of priming and lysosomal damage for NLRP3 activation. Eur. J. Immunol. 40, 620623.
  • Huh S. H., Chung Y. C., Piao Y. et al. (2011) Ethyl pyruvate rescues nigrostriatal dopaminergic neurons by regulating glial activation in a mouse model of Parkinson's disease. J. Immunol. 187, 960969.
  • Huie J. R., Garraway S. M., Baumbauer K. M., Hoy K. C., Jr, Beas B. S., Montgomery K. S., Bizon J. L. and Grau J. W. (2012) Brain-derived neurotrophic factor promotes adaptive plasticity within the spinal cord and mediates the beneficial effects of controllable stimulation. Neuroscience 200, 7490.
  • Karpuk N., Burkovetskaya M., Fritz T., Angle A. and Kielian T. (2011) Neuroinflammation leads to region-dependent alterations in astrocyte gap junction communication and hemichannel activity. J. Neurosci. 31, 414425.
  • Kettenmann H., Hanisch U. K., Noda M. and Verkhratsky A. (2011) Physiology of microglia. Physiol. Rev. 91, 461553.
  • Kielian T. (2008) Glial connexins and gap junctions in CNS inflammation and disease. J. Neurochem. 106, 10001016.
  • Kigerl K. A., Gensel J. C., Ankeny D. P., Alexander J. K., Donnelly D. J. and Popovich P. G. (2009) Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J. Neurosci. 29, 1343513444.
  • Kim S., Steelman A. J., Zhang Y., Kinney H. C. and Li J. (2012) Aberrant upregulation of astroglial ceramide potentiates oligodendrocyte injury. Brain Pathol. 22, 4157.
  • Kobayashi Y., Kiguchi N., Maeda T., Ozaki M. and Kishioka S. (2012) The critical role of spinal ceramide in the development of partial sciatic nerve ligation-induced neuropathic pain in mice. Biochem. Biophys. Res. Commun. 421, 318322.
  • Kovacs A. D. and Pearce D. A. (2008) Attenuation of AMPA receptor activity improves motor skills in a mouse model of juvenile Batten disease. Exp. Neurol. 209, 288291.
  • Kovacs A. D., Weimer J. M. and Pearce D. A. (2006) Selectively increased sensitivity of cerebellar granule cells to AMPA receptor-mediated excitotoxicity in a mouse model of Batten disease. Neurobiol. Dis. 22, 575585.
  • Kovacs A. D., Saje A., Wong A., Szenasi G., Kiricsi P., Szabo E., Cooper J. D. and Pearce D. A. (2011) Temporary inhibition of AMPA receptors induces a prolonged improvement of motor performance in a mouse model of juvenile Batten disease. Neuropharmacology 60, 405409.
  • Lamkanfi M. (2011) Emerging inflammasome effector mechanisms. Nat. Rev. Immunol. 11, 213220.
  • Lee G. S., Subramanian N., Kim A. I., Aksentijevich I., Goldbach-Mansky R., Sacks D. B., Germain R. N., Kastner D. L. and Chae J. J. (2012) The calcium-sensing receptor regulates the NLRP3 inflammasome through Ca2 +  and cAMP. Nature 492, 123127.
  • Lim M. J., Alexander N., Benedict J. W., Chattopadhyay S., Shemilt S. J., Guerin C. J., Cooper J. D. and Pearce D. A. (2007) IgG entry and deposition are components of the neuroimmune response in Batten disease. Neurobiol. Dis. 25, 239251.
  • Liu S. and Kielian T. (2011) MyD88 is pivotal for immune recognition of Citrobacter koseri and astrocyte activation during CNS infection. J. Neuroinflammation 8, 35.
  • Maezawa I. and Jin L. W. (2010) Rett syndrome microglia damage dendrites and synapses by the elevated release of glutamate. J. Neurosci. 30, 53465356.
  • McCormack A. L., Atienza J. G., Johnston L. C., Andersen J. K., Vu S. and Di Monte D. A. (2005) Role of oxidative stress in paraquat-induced dopaminergic cell degeneration. J. Neurochem. 93, 10301037.
  • McCoy M. K. and Tansey M. G. (2008) TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease. J. Neuroinflammation 5, 45.
  • Meissner F., Molawi K. and Zychlinsky A. (2010) Mutant superoxide dismutase 1-induced IL-1beta accelerates ALS pathogenesis. Proc. Natl Acad. Sci. USA 107, 1304613050.
  • Mencarelli C. and Martinez-Martinez P. (2013) Ceramide function in the brain: when a slight tilt is enough. Cell. Mol. Life Sci. 70, 181203.
  • Mika T. and Prochnow N. (2012) Functions of connexins and large pore channels on microglial cells: the gates to environment. Brain Res. 1487, 1624.
  • Mitchell J. B., Russo A., Biaglow J. E. and McPherson S. (1983) Cellular glutathione depletion by diethyl maleate or buthionine sulfoximine: no effect of glutathione depletion on the oxygen enhancement ratio. Radiat. Res. 96, 422428.
  • Munroe P. B., Mitchison H. M., O'Rawe A. M. et al. (1997) Spectrum of mutations in the Batten disease gene, CLN3. Am. J. Hum. Genet. 61, 310316.
  • Murakami T., Ockinger J., Yu J., Byles V., McColl A., Hofer A. M. and Horng T. (2012) Critical role for calcium mobilization in activation of the NLRP3 inflammasome. Proc. Natl Acad. Sci. USA 109, 1128211287.
  • Noda M., Nakanishi H. and Akaike N. (1999) Glutamate release from microglia via glutamate transporter is enhanced by amyloid-beta peptide. Neuroscience 92, 14651474.
  • Osorio N. S., Sampaio-Marques B., Chan C. H., Oliveira P., Pearce D. A., Sousa N. and Rodrigues F. (2009) Neurodevelopmental delay in the Cln3Deltaex7/8 mouse model for Batten disease. Genes Brain Behav. 8, 337345.
  • Palmer D. N., Bayliss S. L., Clifton P. A. and Grant V. J. (1993) Storage bodies in the ceroid-lipofuscinoses (Batten disease): low-molecular-weight components, unusual amino acids and reconstitution of fluorescent bodies from non-fluorescent components. J. Inherit. Metab. Dis. 16, 292295.
  • Pearce D. A., Atkinson M. and Tagle D. A. (2004) Glutamic acid decarboxylase autoimmunity in Batten disease and other disorders. Neurology 63, 20012005.
  • Persaud-Sawin D. A. and Boustany R. M. (2005) Cell death pathways in juvenile Batten disease. Apoptosis 10, 973985.
  • Petrilli V., Papin S., Dostert C., Mayor A., Martinon F. and Tschopp J. (2007) Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death Differ. 14, 15831589.
  • Pontikis C. C., Cella C. V., Parihar N. et al. (2004) Late onset neurodegeneration in the Cln3-/- mouse model of juvenile neuronal ceroid lipofuscinosis is preceded by low level glial activation. Brain Res. 1023, 231242.
  • Pontikis C. C., Cotman S. L., MacDonald M. E. and Cooper J. D. (2005) Thalamocortical neuron loss and localized astrocytosis in the Cln3Deltaex7/8 knock-in mouse model of Batten disease. Neurobiol. Dis. 20, 823836.
  • Puranam K., Qian W. H., Nikbakht K., Venable M., Obeid L., Hannun Y. and Boustany R. M. (1997) Upregulation of Bcl-2 and elevation of ceramide in Batten disease. Neuropediatrics 28, 3741.
  • Rakheja D., Narayan S. B. and Bennett M. J. (2007) Juvenile neuronal ceroid-lipofuscinosis (Batten disease): a brief review and update. Curr. Mol. Med. 7, 603608.
  • Rosenbaugh E. G., Roat J. W., Gao L. et al. (2010) The attenuation of central angiotensin II-dependent pressor response and intra-neuronal signaling by intracarotid injection of nanoformulated copper/zinc superoxide dismutase. Biomaterials 31, 52185226.
  • Rossol M., Pierer M., Raulien N. et al. (2012) Extracellular Ca2 +  is a danger signal activating the NLRP3 inflammasome through G protein-coupled calcium sensing receptors. Nat. Commun. 3, 1329.
  • Rothwell N. (2003) Interleukin-1 and neuronal injury: mechanisms, modification, and therapeutic potential. Brain Behav. Immun. 17, 152157.
  • Saha A., Sarkar C., Singh S. P., Zhang Z., Munasinghe J., Peng S., Chandra G., Kong E. and Mukherjee A. B. (2012) The blood-brain barrier is disrupted in a mouse model of infantile neuronal ceroid lipofuscinosis: amelioration by resveratrol. Hum. Mol. Genet. 21, 22332244.
  • Salek R. M., Pears M. R., Cooper J. D., Mitchison H. M., Pearce D. A., Mortishire-Smith R. J. and Griffin J. L. (2011) A metabolomic comparison of mouse models of the Neuronal Ceroid Lipofuscinoses. J. Biomol. NMR 49, 175184.
  • Santello M., Cali C. and Bezzi P. (2012) Gliotransmission and the tripartite synapse. Adv. Exp. Med. Biol. 970, 307331.
  • Seehafer S. S., Ramirez-Montealegre D., Wong A. M. et al. (2011) Immunosuppression alters disease severity in juvenile Batten disease mice. J. Neuroimmunol. 230, 169172.
  • Shimada K., Crother T. R., Karlin J. et al. (2012) Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity 36, 401414.
  • Staropoli J. F., Haliw L., Biswas S. et al. (2012) Large-scale phenotyping of an accurate genetic mouse model of JNCL identifies novel early pathology outside the central nervous system. PLoS ONE 7, e38310.
  • Steel J. C., Waldmann T. A. and Morris J. C. (2012) Interleukin-15 biology and its therapeutic implications in cancer. Trends Pharmacol. Sci. 33, 3541.
  • Stellwagen D. and Malenka R. C. (2006) Synaptic scaling mediated by glial TNF-alpha. Nature 440, 10541059.
  • Stoll G., Jander S., Siebler M. and Schroeter M. (2000) Immunological aspects of ischaemic stroke: therapeutic implications. CNS Drugs 14, 213228.
  • Thornton P., Pinteaux E., Gibson R. M., Allan S. M. and Rothwell N. J. (2006) Interleukin-1-induced neurotoxicity is mediated by glia and requires caspase activation and free radical release. J. Neurochem. 98, 258266.
  • Tuxworth R. I., Chen H., Vivancos V., Carvajal N., Huang X. and Tear G. (2011) The Batten disease gene CLN3 is required for the response to oxidative stress. Hum. Mol. Genet. 20, 20372047.
  • Vandanmagsar B., Youm Y. H., Ravussin A., Galgani J. E., Stadler K., Mynatt R. L., Ravussin E., Stephens J. M. and Dixit V. D. (2011) The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat. Med. 17, 179188.
  • Wang G., Dinkins M., He Q., Zhu G., Poirier C., Campbell A., Mayer-Proschel M. and Bieberich E. (2012) Astrocytes secrete exosomes enriched with proapoptotic ceramide and prostate apoptosis response 4 (PAR-4): potential mechanism of apoptosis induction in Alzheimer disease (AD). J. Biol. Chem. 287, 2138421395.
  • Zhou R., Yazdi A. S., Menu P. and Tschopp J. (2011) A role for mitochondria in NLRP3 inflammasome activation. Nature 469, 221225.